Latest

18:57
【SSY GROUP (02005.HK): Gadobutrol injection and indocyanine green for injection approved, enhancing imaging and critical care product portfolio】NewTimeSpace News: On 27 August 2026, SSY GROUP (02005.HK) announced that it has obtained NMPA production registration approvals for gadobutrol injection (7.5ml: 4.5354g, Category 4 chemical drug) and indocyanine green for injection (25mg, Category 3 chemical drug), both deemed to have passed consistency evaluation; the products are used for contrast-enhanced MRI examinations and the diagnosis of liver diseases respectively, and together with the Group's already-registered APIs complete its integrated layout, supporting expansion into the medical imaging and critical care markets.
Tag： SSY Group02005.HKClinical Progress
18:56
【IB SETTLEMENT (00147.HK): Issues price and volume fluctuation announcement; in preliminary talks over potential technology investment】NewTimeSpace News: On 27 August 2026, IB SETTLEMENT (00147.HK) announced at the request of the Exchange that, in response to an increase in the share price and trading volume, the Board is not aware of any reasons for the fluctuation; the Company is in preliminary discussions with an independent third party over a potential investment opportunity in the technology sector, with terms not yet finalized and no formal agreement signed, and the potential investment, if materialized, may constitute a discloseable transaction.
Tag： IB SETTLEMENT00147.HKPrice Fluctuation
18:53
【LIVZON PHARMA (01513.HK): Lecankitug injection approved for marketing; first domestic IL-17A/F dual-target biologic in China】NewTimeSpace News: On 27 August 2026, LIVZON PHARMA (01513.HK) announced that its controlling subsidiary has received the NMPA Drug Registration Certificate for lecankitug injection (subcutaneous injection), with approval number Guoyao Zhunzi S20260065 valid until 24 August 2031; the drug is China's first independently developed IL-17A/F dual-target biologic for adult patients with moderate-to-severe plaque psoriasis, with Phase III data showing superiority over secukinumab control in onset of action, lesion clearance and long-term efficacy, and cumulative R&D investment of approximately RMB 223.31 million.
Tag： LIVZON PHARMA01513.HKClinical Progress
18:40
【SUN KONG HLDGS (08631.HK): Receives resumption guidance from HKEX; trading remains suspended, delisting risk if not resumed by July 2027】NewTimeSpace News: On 27 August 2026, SUN KONG HLDGS (08631.HK) announced that it received resumption guidance from HKEX on 24 August 2026, covering six conditions including publication of outstanding financial results, independent forensic investigation and internal control review; trading has been suspended since 2 July 2026, and if trading is not resumed by 1 July 2027, HKEX may proceed with the cancellation of the Company's listing.
Tag： SUN KONG HLDGS08631.HKresumption guidance
18:38
【CSPC PHARMA (01093.HK): High-potency amylin receptor agonist SYH2092 injection approved for clinical trials in China】NewTimeSpace News: On 27 August 2026, CSPC PHARMA (01093.HK) announced that its SYH2092 injection, an amylin receptor agonist, has been approved by the NMPA to conduct clinical trials in China; preclinical studies showed higher target agonistic activity, significant weight loss effects and durable maintenance versus multiple amylin analogues in development, with synergistic weight loss when combined with the Group's GLP-1/GIP receptor dual biased agonist, potentially benefiting weight management in obesity and glycemic control in adult T2DM patients.
Tag： CSPC PHARMA01093.HKClinical Trial
18:36
【FOSUN PHARMA (02196.HK): Repurchases 217,000 H shares for approximately HKD 3.587 million】NewTimeSpace News: On 27 August 2026, FOSUN PHARMA (02196.HK) announced that, pursuant to the general mandate granted at the annual general meeting and other meetings, it repurchased 217,000 H shares in the open market on the same day, at an average price of HKD 16.53 per share and a total amount of approximately HKD 3.587 million, with the highest and lowest prices at HKD 16.59 and HKD 16.45 respectively; the repurchased shares will be held as treasury shares with use including but not limited to cancellation.
Tag： FOSUN PHARMA02196.HKShare Buyback
18:34
【CCB (00939.HK): Mr. Yang Qiang assumes office as independent non-executive director after qualification approval】NewTimeSpace News: On 27 August 2026, CCB (00939.HK) announced that the 2025 annual general meeting held on 26 June 2026 approved the election of Mr. Yang Qiang as an independent non-executive director, and that the National Financial Regulatory Administration has approved his qualification, with Mr. Yang officially assuming office.
Tag： CCB00939.HKqualification approval
18:33
【HK Stock Connect Daily Report: ZJ INNOLIGHT Officially Added to Stock Connect, Z.AI Surges Over 12%, Southbound Net Buying Reaches HKD 3.18 Billion - 20260827】NewTimeSpace News: On 27 August 2026, the three major Hong Kong indices retreated in volatile trading, with the Hang Seng Index down 0.34% to 25,565.74 points, the Hang Seng TECH Index down 0.13%, and turnover at HKD 233.5 billion. Driven by NVIDIA's better-than-expected results, AI hardware stocks strengthened, with YOFC up 10.31% and KB LAMINATES up 10.51%; the twin large-language-model stocks shone, with Z.AI up 12.62% and MINIMAX up 3.83%. BIDU-SW gained 5.34% as its dual primary listing takes effect on 1 September, lifting inclusion expectations. Southbound capital recorded net buying of HKD 3.18 billion. ZJ INNOLIGHT was officially added to Stock Connect; SHEIN-W's public offering closed, with listing set for 1 September.
Tag： HK Stock Connect Daily ReportHANSOH PHARMAZ.AIPenghua CNI HK Equities Innovative Drugs ETFChina Universal CNI HK Equities Innovative Drugs ETF
18:32
【TWINTEK (06182.HK): Substantial shareholder Li Haoyuan disposes of 90 million shares, reducing holding to zero】NewTimeSpace News: On 27 August 2026, TWINTEK (06182.HK) announced that substantial shareholder Mr. Li Haoyuan disposed of 90,000,000 shares of the Company on the same day, representing approximately 11.25% of the issued share capital; following the disposal, Mr. Li no longer holds any shares and ceases to be a substantial shareholder.
Tag： TWINTEK06182.HKDisposal of Shares
18:32
【KONG SUN HOLD(00295.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 48.44 million, loss widened by 307.94% YoY】NewTimeSpace News: August 27, 2026, KONG SUN HOLD(00295.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 150.88 million, decreased by 6.28% YoY.
Tag： KONG SUN HOLD00295.HKLoss widens
18:26
【GUANGDONG INV (00270.HK): Subsidiary completes RMB 500 million corporate bond issuance at coupon of 1.49%, oversubscribed 7.42 times】NewTimeSpace News: On 27 August 2026, GUANGDONG INV (00270.HK) announced that its indirectly wholly-owned subsidiary Guangdong Yuehai Water Investment Co., Ltd. has completed the issuance of the first tranche of corporate bonds with an aggregate principal of RMB 500,000,000, a 3-year term, a coupon rate of 1.49% and a subscription multiple of 7.42, with interest accruing from 27 August 2026; proceeds will be used to repay existing borrowings and replenish working capital.
Tag： GUANGDONG INV00270.HKBond Issuance
18:08
【S HARBOURHOLD (01663.HK): Chairman and substantial shareholder Wang Linbing increases stake with 9.258 million shares at average HKD 0.052 each】NewTimeSpace News: On 27 August 2026, S HARBOURHOLD (01663.HK) announced that Chairman and substantial shareholder Mr. Wang Linbing purchased 9,258,000 ordinary shares of the Company in the open market on the same day, at an average price of approximately HKD 0.052 per share and a highest price of HKD 0.053 per share.
Tag： S HARBOURHOLD01663.HKShare Increase
17:46
【MOBI DEV (00947.HK): Supplies multi-beam antennas for three Mexico venues at 2026 FIFA World Cup; initial cooperation estimated at over USD 1 million】NewTimeSpace News: On 27 August 2026, MOBI DEV (00947.HK) announced that, together with local operators, the Group supplied high-performance multi-beam antenna products for three venues of the 2026 FIFA World Cup in Mexico, with the estimated initial cooperation exceeding USD 1 million and plans to continue expanding product supply in the Mexican market; the Group has also made breakthroughs in AI smart tracking antennas and green antennas, building core technology reserves for 5G-A and 6G evolution; the announcement cautioned that winning projects does not constitute a transaction contract and specific terms are subject to final contracts.
Tag： MOBI DEV00947.HKwon the bid2026 World Cup
17:41
【SH IND URBAN (00563.HK): Subsidiary leases 12 floors of property in Changning, Shanghai for branded apartments; connected and discloseable transaction】NewTimeSpace News: On 27 August 2026, SH IND URBAN (00563.HK) announced that its indirectly wholly-owned subsidiary has leased 12 floors of the building at No. 89 Jiangsu North Road, Changning, Shanghai (total GFA of approximately 10,359.40 sqm) for branded apartments, with a term of up to 15 years renewable every three years and rent rising 3% every five years; the expected unaudited value of the right-of-use asset is approximately RMB 90.1 million; as the percentage ratios exceed 5%, the lease constitutes a connected and discloseable transaction subject to independent shareholders' approval, with a circular expected on or before 17 September 2026.
Tag： SH IND URBAN00563.HKProperty lease
17:37
【HKR INT'L (00480.HK): Proposes to sell entire equity interest in target company for HKD 106.5 million; estimated net gain of about HKD 5.2 million】NewTimeSpace News: On 27 August 2026, HKR INT'L (00480.HK) announced that its wholly-owned subsidiary Hanbright Assets Limited conditionally agreed to sell the entire equity interest of the target company to Apex Future International Limited for HKD 106.5 million; the target company holds two residential properties in Discovery Bay and Mid-Levels, with the consideration referenced to an independent valuation of HKD 106.3 million, and the Group expects an estimated net gain of approximately HKD 5.2 million with net proceeds used as general working capital; the transaction constitutes a discloseable and connected transaction subject to independent shareholders' approval.
Tag： HKR INT00480.HKShare Sale
17:37
【ZOOMLION (01157.HK): Extends Duration of First ESOP to April 2032】NewTimeSpace News: On 27 August 2026, ZOOMLION (01157.HK) announced Board approval to extend the duration of its first employee stock ownership plan by 60 months to 27 April 2032, following approval by plan holders on 21 August 2026; the plan was previously extended by 36 months in March 2024.
Tag： ZOOMLION01157.HKEquity Incentive
17:32
【AMS TRANSPORT (00077.HK): Prof. So Wai Man Elected Independent Non-Executive Director; Kwong Ki Chi Retires】NewTimeSpace News: On 27 August 2026, AMS TRANSPORT (00077.HK) announced that Professor So Wai Man was elected as an independent non-executive director and audit committee chairman with an annual fee of HKD 384,000, while Kwong Ki Chi retired from the Board at the annual general meeting.
Tag： AMS TRANSPORT00077.HKBoard Change
17:32
【C&D INTL GROUP(01908.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 825.37 million, YoY decrease of 9.67%】NewTimeSpace News: August 27, 2026, C&D INTL GROUP(01908.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 17.8 billion, decreased by 47.91% YoY.
Tag： C&D INTL GROUP01908.HKProfit declined
17:32
【BEIJING ENT(00392.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 3.54 billion, YoY increase of 4%】NewTimeSpace News: August 27, 2026, BEIJING ENT(00392.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 45 billion, increased by 1.07% YoY.
Tag： BEIJING ENT00392.HKprofit growth
17:32
【POWERLONG CM(09909.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 139.66 million, YoY decrease of 23.6%】NewTimeSpace News: August 27, 2026, POWERLONG CM(09909.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.21 billion, decreased by 7.06% YoY.
Tag： POWERLONG CM09909.HKProfit declined
Previous1..2425 262728..492     492 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments